Another potential target is extracellular signal-regulated kinase 5 (ERK5) signalling since myeloid cell-selective knockout of ERK5 blocks TAM proliferation and metastatic tumour loads in a metastatic melanoma mouse model [59]. The gene discussed is MAPK7; the disease is metastatic neoplasm.